Grail plans to raise $1 billion for liquid biopsy clinical trials

January 11, 2017 Leave a comment 2,890 Views

Illumina, Inc. (NASDAQ: ILMN), today announced that GRAIL has received indications of interest to invest approximately $1B for its Series B financing, primarily from undisclosed private and strategic investors. GRAIL intends to raise additional capital in the Series B financing ...

Exosome RNA Exosome RNA Research & Industry News

Tag Archives: series b

Grail plans to raise $1 billion for liquid biopsy clinical trials

EV study reveals protein kinases significantly contribute to the immunodeficiency in HIV patients

Exosomes – powerful weapon for cancer nano-immunoengineering

Find One-stop Exosome Services at Creative Biolabs for Various Applications

Innate immunity communicates using the language of extracellular microvesicles

WO2021033990 – Composition Comprising Exosomes Derived from Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cell Precursor for Prevention or Treatment of Non-Alcoholic Steatohepatitis

Researchers use new tool to study how stress impacts outer membrane vesicle composition in root-colonizing bacteria